Overview
Mengxing Cai practices practicing medicine in Wenzhou, China.
Their clinical expertise encompasses Atrial Fibrillation, Heart Block, Heart Failure, and Acute Coronary Syndrome.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Mengxing Cai
Is Mengxing Cai a top-rated expert for Atrial Fibrillation?
MediFind is an objective health platform that identifies experts based on real-world data. Mengxing Cai is classified as an Experienced expert for Atrial Fibrillation, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Mengxing Cai participate in research or clinical trials?
Yes. Mengxing Cai has published 10 articles and abstracts on conditions like Atrial Fibrillation. You can view a list of Mengxing Cai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Coronary SyndromeCai isExperienced. Learn about Acute Coronary Syndrome.
- Atrial FibrillationCai isExperienced. Learn about Atrial Fibrillation.
- Heart BlockCai isExperienced. Learn about Heart Block.
- Heart FailureCai isExperienced. Learn about Heart Failure.